Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer.
Adrien GuilloteauMichal AbrahamowiczOlayide BoussariValérie JoosteThomas AparicioCatherine QuantinKarine Le MalicotChristine BinquetPublished in: BMC medical research methodology (2021)
clinicaltrials.gov, NCT00952029 . Registered 8 August 2009.